Why the study?
Does perindopril prevent age-related changes in kidney structure and function in normotensive male Wistar rats?
Does perindopril prevent age-related changes in kidney structure and function in normotensive male Wistar rats?
Chronic ACE inhibition with perindopril delays specific age-related functional and structural declines in the kidneys of normotensive rats.
Answers are grounded in this paper and cite their sources.
Does not support clinical use in human renal aging; leaves open translation from rat models.
The effect of angiotensin I-converting enzyme inhibition (ACEI) on the age-related changes in the kidney structure and function was investigated in rodents. Normotensive male Wistar (WAG)/Rij rats were treated with perindopril from the age of 6 mo to the day of killing at 12, 24, or 30 mo. Mean blood pressure, constant from 6 to 30 mo, was reduced by 19 mmHg in treated animals. With age, the major functional modifications were a decrease in glomerular filtration rate and in renal blood flow, a rise in intrarenal vascular resistance (IVR), a reduced tubular reabsorption of salts, and a progressive increase in proteinuria. ACEI significantly reduced IVR and proteinuria. From a structural point of view, the glomeruli showed 1) an increase in size, 2) a decrease in capillary surface, 3) a diffuse thickening of the glomerular basement membrane, 4) an expansion of the mesangial matrix, and 5) an accumulation of albumin droplets in podocytes inducing 6) a dispersed focal and segmental glomerulosclerosis which, at 30 mo, affected < 2% of glomeruli. Of these six age-related structural changes, ACEI delayed the appearance of the three latter changes.
No takes yet. Share an insight, caveat, or question.
Heudes et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: